A new study shows apolipoprotein B (apoB) and non-high-density-lipoprotein (non-HDL) cholesterol — but not low-density-lipoprotein (LDL) cholesterol — are associated with increased risk for all-cause ...

LDL cholesterol still drives treatment decisions in assessing heart disease risk, but a new study suggests apolipoprotein B (apoB), which measures artery-clogging particles, could do a better job. In ...

The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and ...

People whose LDL cholesterol is in the normal range—even those without metabolic risk factors—may yet have levels of apolipoprotein B (apoB) that predict an elevated risk of future atherosclerotic ...

Modern medicine is improving in precision, identifying exactly who needs treatment and who doesn’t. In heart disease prevention, ApoB may outperform traditional cholesterol measures in predicting risk ...

Share on Pinterest A new study suggests that not only is apoB testing effective for guiding cholesterol treatment, but also cost-effective. Image credit: aire images/Getty Images A study suggests that ...

Share on Pinterest Cholesterol levels could be a good predictor of coronary artery disease risk. Olena Smyrnova/Stocksy Coronary artery disease is a serious but common type of heart disease that can ...